Saturday, 20 April 2024
  
Login

Australia's most trusted
source of pharma news

Saturday, 20 April 2024
Listen to this story 
News

DoH in reimbursement hot seat

Posted 8 August 2022 PM

A grilling for Department of Health official Penny Shakespeare today as Specialised Therapeutics Australia (STA) launched a legal challenge over six unsuccessful submissions to have a genomic breast cancer test reimbursed.

The Aussie pharma is seeking the unredacted deliberations relating to MSAC's decision to reject reimbursement of the Oncotype DX genomic breast cancer test, which were sought under the Freedom of Information Act.

To see the whole article, please login

Popular

The hottest new career in pharma
Meet AbbVie's new HR Director
Pharma to cut 50% of staff
Biggest PBAC headaches revealed
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (4)

Sales & Customer Relations (22)

Clinical & Medical, R&D (13)

Regulatory, Pharmacovigilance & QA (7)

Devices (1)

Other (25)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2024 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home